Insider Transactions in Q3 2024 at Allogene Therapeutics, Inc. (ALLO)

ALLO Quotes by TradingView

Insider Transaction List (Q3 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
Aug 21 2024
Earl Martin Douglas SVP, General Counsel
SELL
Payment of exercise price or tax liability
Direct
28,310 -5.93%
$56,620 $2.79 P/Share

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALLO